185 related articles for article (PubMed ID: 18455873)
21. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder.
Brietzke E; Stertz L; Fernandes BS; Kauer-Sant'anna M; Mascarenhas M; Escosteguy Vargas A; Chies JA; Kapczinski F
J Affect Disord; 2009 Aug; 116(3):214-7. PubMed ID: 19251324
[TBL] [Abstract][Full Text] [Related]
22. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
23. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.
Padmos RC; Hillegers MH; Knijff EM; Vonk R; Bouvy A; Staal FJ; de Ridder D; Kupka RW; Nolen WA; Drexhage HA
Arch Gen Psychiatry; 2008 Apr; 65(4):395-407. PubMed ID: 18391128
[TBL] [Abstract][Full Text] [Related]
24. Serum markers support disease-specific glial pathology in major depression.
Schroeter ML; Abdul-Khaliq H; Krebs M; Diefenbacher A; Blasig IE
J Affect Disord; 2008 Dec; 111(2-3):271-80. PubMed ID: 18430474
[TBL] [Abstract][Full Text] [Related]
25. The GLO1 C332 (Ala111) allele confers autism vulnerability: family-based genetic association and functional correlates.
Gabriele S; Lombardi F; Sacco R; Napolioni V; Altieri L; Tirindelli MC; Gregorj C; Bravaccio C; Rousseau F; Persico AM
J Psychiatr Res; 2014 Dec; 59():108-16. PubMed ID: 25201284
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease.
Brooks WM; Lynch PJ; Ingle CC; Hatton A; Emson PC; Faull RL; Starkey MP
Brain Res; 2007 Jan; 1127(1):127-35. PubMed ID: 17109828
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment.
Bezchlibnyk YB; Xu L; Wang JF; Young LT
Brain Res; 2007 May; 1147():213-7. PubMed ID: 17395163
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia.
Carletti R; Corsi M; Melotto S; Caberlotto L
Eur J Neurosci; 2005 Mar; 21(6):1712-8. PubMed ID: 15845098
[TBL] [Abstract][Full Text] [Related]
29. Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder.
Walz JC; Andreazza AC; Frey BN; Cacilhas AA; Ceresér KM; Cunha AB; Weyne F; Stertz L; Santin A; Gonçalves CA; Kapczinski F
Neurosci Lett; 2007 Mar; 415(1):87-9. PubMed ID: 17234344
[TBL] [Abstract][Full Text] [Related]
30. Behavioral and gene expression analyses of Wfs1 knockout mice as a possible animal model of mood disorder.
Kato T; Ishiwata M; Yamada K; Kasahara T; Kakiuchi C; Iwamoto K; Kawamura K; Ishihara H; Oka Y
Neurosci Res; 2008 Jun; 61(2):143-58. PubMed ID: 18343518
[TBL] [Abstract][Full Text] [Related]
31. Catechol-O-methyltransferase gene variants in mood disorders in the Italian population.
Serretti A; Rotondo A; Lorenzi C; Smeraldi E; Cassano GB
Psychiatr Genet; 2006 Oct; 16(5):181-2. PubMed ID: 16969269
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent changes of glyoxalase I expression in human brain.
Kuhla B; Boeck K; Lüth HJ; Schmidt A; Weigle B; Schmitz M; Ogunlade V; Münch G; Arendt T
Neurobiol Aging; 2006 Jun; 27(6):815-22. PubMed ID: 15950319
[TBL] [Abstract][Full Text] [Related]
33. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
Uezato A; Meador-Woodruff JH; McCullumsmith RE
Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies.
Engelen L; Ferreira I; Brouwers O; Henry RM; Dekker JM; Nijpels G; Heine RJ; van Greevenbroek MM; van der Kallen CJ; Blaak EE; Feskens EJ; ten Cate H; Stehouwer CD; Schalkwijk CG
J Hypertens; 2009 Jul; 27(7):1399-403. PubMed ID: 19412133
[TBL] [Abstract][Full Text] [Related]
35. Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population.
Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
Neurosci Res; 2008 Dec; 62(4):211-5. PubMed ID: 18804497
[TBL] [Abstract][Full Text] [Related]
36. Glyoxalase I (GLO1) is up-regulated in pancreatic cancerous tissues compared with related non-cancerous tissues.
Wang Y; Kuramitsu Y; Ueno T; Suzuki N; Yoshino S; Iizuka N; Akada J; Kitagawa T; Oka M; Nakamura K
Anticancer Res; 2012 Aug; 32(8):3219-22. PubMed ID: 22843895
[TBL] [Abstract][Full Text] [Related]
37. Identification of thermostable glyoxalase I in the fission yeast Schizosaccharomyces pombe.
Takatsume Y; Izawa S; Inoue Y
Arch Microbiol; 2004 May; 181(5):371-7. PubMed ID: 15042280
[TBL] [Abstract][Full Text] [Related]
38. Minor physical anomalies in affective disorders. A review of the literature.
Tényi T; Trixler M; Csábi G
J Affect Disord; 2009 Jan; 112(1-3):11-8. PubMed ID: 18508129
[TBL] [Abstract][Full Text] [Related]
39. Identification of glyoxalase 1 polymorphisms associated with enzyme activity.
Peculis R; Konrade I; Skapare E; Fridmanis D; Nikitina-Zake L; Lejnieks A; Pirags V; Dambrova M; Klovins J
Gene; 2013 Feb; 515(1):140-3. PubMed ID: 23201419
[TBL] [Abstract][Full Text] [Related]
40. Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression.
Belzeaux R; Formisano-Tréziny C; Loundou A; Boyer L; Gabert J; Samuelian JC; Féron F; Naudin J; Ibrahim EC
J Psychiatr Res; 2010 Dec; 44(16):1205-13. PubMed ID: 20471034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
